Nevertheless, although the anti-HOXA7 AAb assay alone allows no distinction between benign and malignant ovarian tumors, it is able to discriminate patients with well-to moderately differentiated ovarian carcinomas from healthy women [15]. The gene discussed is HOXA7; the disease is ovarian carcinoma.